Kevin Patrick Becker M.D., Ph.D.
Assistant Professor of Medicine (Medical Oncology)
evaluation, treatment and management of all forms of primary brain tumors; consultative support for the medical oncology community for patients with systemic cancer that involves the central nervous system either directly or indirectly; evaluation, treatment and management of difficult general neurology cases; future establishment of a comprehensive care experience for patients with glioblastoma.
kevin_becker faculty-clinics false true false Clinical Trials
Conditions Study Title Brain and Nervous System A Phase I/II Study of the Combination of BKM120 and Bevacizumab in Patients with Refractory Solid Tumors (Phase I) and Relapsed/Refractory Glioblastoma Multiforme (Phase II) Brain and Nervous System A Randomized Phase III open Label Study of Nivolumab versus Bevacizumab and a Safety Study of Nivolumab or Nivolumab in Combination with Ipilimumab in Adult Subjects with Recurrent Glioblastoma (GBM) Brain and Nervous System TAU-2014-1: Phase I Trial of Mibefradil Dihydrochloride with Hypofractionated Re-Irradiation Therapy in Treating Patients with Recurrent Glioblastoma Multiforme (GBM) Bladder, Brain and Nervous System, Breast - Female, Cervix Uteri, Colon, Esophagus, Kidney, Larynx, Lip, Oral Cavity and Pharynx, Liver, Lung, Melanoma, skin, Multiple Myeloma, Non-Hodgkin's Lymphoma, Other Female Genital, Other Male Genital, Pancreas, Prostate, Rectum, Soft Tissue, Stomach, and Thyroid A Phase I, Open-label, dose-escalation study of the safety and pharmacokinetics of MPDL3280A administered intravenously as a single agent to patients with locally advanced or metastatic solid tumors or hematologic malignancies